Pam Akers: Citizens need additional protection from opioid epidemic
The FDA has approved several overdose reversal innovations over the last several years; however, access to these reversal agents is not currently permitted by the state’s 2023 standing orders, which allow nurses and physicians to provide communities products like naloxone without a prescription or patient order.